Abstract | BACKGROUND: OBJECTIVES: To identify small and potent peptide inhibitors of cellular melanin synthesis that are useful for cosmetic and medical applications. METHODS: RESULTS: Predicted active tetrapeptide sequences were R-(F/L)-(C/W)-(G/R)-NH2 . Of the individual tetrapeptides tested, D3 (RFWG-NH2 ) and D5 (RLWG-NH2 ) exhibited high antimelanogenic activities. Tetrapeptide D9 (FRWG-NH2 ) with a sequence identical to that of a portion of α- MSH also showed antimelanogenic activity. Of the tripeptides tested, E5 (FWG-NH2 ), E6 (LWG-NH2 ) and E7 (RWG-NH2 ) were relatively more active. Dipeptide F1 (WG-NH2 ) and monopeptide G1 (G-NH2 , glycinamide) retained activity, but G2 (Ac-G-NH2 ) and G3 ( glycine) did not. The antimelanogenic activities of peptides D3, E5, F1 and G1 were verified in α- MSH-stimulated human epidermal melanocytes. Commercially available G-NH2 ·HCl suppressed the phosphorylation levels of cAMP-responsive element binding protein, protein levels of microphthalmia-associated transcription factor and tyrosinase, l-tyrosine hydroxylase activity of tyrosinase, and the melanin levels in stimulated cells. CONCLUSIONS:
|
Authors | J H Kim, J K Seok, Y M Kim, Y C Boo |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 181
Issue 1
Pg. 128-137
(07 2019)
ISSN: 1365-2133 [Electronic] England |
PMID | 30637717
(Publication Type: Journal Article)
|
Copyright | © 2019 British Association of Dermatologists. |
Chemical References |
- Dermatologic Agents
- Dipeptides
- Melanins
- Peptide Library
- glycine amide
- alpha-MSH
- tryptophylglycine
- Glycine
|
Topics |
- Animals
- Cell Line, Tumor
- Dermatologic Agents
(chemical synthesis, pharmacology, therapeutic use)
- Dipeptides
(chemical synthesis, pharmacology, therapeutic use)
- Glycine
(analogs & derivatives, chemical synthesis, pharmacology, therapeutic use)
- Humans
- Hyperpigmentation
(drug therapy)
- Melanins
(antagonists & inhibitors, biosynthesis)
- Melanocytes
(drug effects, metabolism)
- Mice
- Peptide Library
- alpha-MSH
(metabolism)
|